Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Consideration for Multigene Panel Testing Outside of Cancer-Specific Genetic Testing.

Oncology nursing forum - 12 Jun 2025

Smith Alicia Lauren, Okut Hayrettin, Ablah Elizabeth, Ward Maggie

Abstract excerpt

OBJECTIVES: To assess the National Comprehensive Cancer Network (NCCN) guidelines for the care of patients with malignancies and capture the expected number of patients with pathogenic variants (PVs) linked to hereditary cancers. This research assessed how well the NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, version 3.2023, and Genetic/Familial High-Risk Assessment: Colorectal,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Breast Neoplasms
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Midwestern United States

Share to Neoplasms

Share to Practice Guidelines as Topic

Share to Risk Assessment

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 40577580
DOI: 10.1188/25.ONF.293-301
PMCID: PMC12169354

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Consideration for Multigene Panel Testing Outside of Cancer-Specific Genetic Testing.PMID 40577580Read ↗

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patientsSemantic proximity Read ↗

Multigene Testing for Hereditary Cancer: When, Why, and How.Semantic proximity Read ↗

Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology.Semantic proximity Read ↗

Changes in multi-gene cancer panels for children: A 4-year retrospective review.Semantic proximity Read ↗

Identification of Patients at Elevated Cancer Risk through a Community-Based Genetic Testing Program.Semantic proximity Read ↗

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline.Semantic proximity Read ↗

Cancer risk assessment using genetic panel testing: considerations for clinical application.Semantic proximity Read ↗

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026.Semantic proximity Read ↗

Cancer Genetic Predisposition and Clinical Applications-A Narrative Review on Germline Genetic Testing, High-Risk Cancer Surveillance and Management.Semantic proximity Read ↗

Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome.Semantic proximity Read ↗

Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients.Semantic proximity Read ↗

Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.